An van Es-Johansson joins management team at AlzeCure Pharma – resigns from Board of Directors
PRESS RELEASE, March 3, 2020 AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company developing a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that An van Es-Johansson is joining the company’s management team. In doing so, she is directly involved in the development of AlzeCure's candidate portfolio. She has resigned from AlzeCure Pharma AB's Board of Directors as a result of the new position.An van Es-Johansson will as of today be part of AlzeCure Pharma’s management